Composite endpoints increase statistical power but can mask clinically important...
Africa Trials
3,515
US Trials
159,433
Gap Ratio
45x
Nations
54
Key Finding
Africa hosts 23,873 trials across 54 nations with extreme geographic concentration.
Regional Comparison
Distribution Analysis
Inequality Profile
Temporal & Structural
Why It Matters
Composite endpoints increase statistical power but can mask clinically important differences between components — a particular risk when endpoints validated in Northern populations may not apply in Africa.
The Evidence 125 words · target 156
In the methodological architecture of African clinical research, does the pattern of composite endpoint complexity reveal structural inequity in African research investment? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the Shannon entropy of trial allocation as the primary estimand using registry metadata for each nation. Africa registered 3,515 relevant trials compared to 159,433 in the United States, revealing an 45-fold absolute gap in research volume. Shannon entropy of the trial distribution was 2.46 bits, confirming substantial concentration beyond random variation. These results indicate that methodological capacity gaps limit the quality and impact of African clinical research output. Interpretation is limited by reliance on ClinicalTrials.gov alone, which may undercount locally registered African studies.
Sentence Structure
Question
In the methodological architecture of African clinical research, does the pattern of composite endpoint complexity reveal structural inequity in African research investment?
Dataset
This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.
Method
gov through April 2026.
Primary Result
Investigators computed the Shannon entropy of trial allocation as the primary estimand using registry metadata for each nation.
Robustness
Africa registered 3,515 relevant trials compared to 159,433 in the United States, revealing an 45-fold absolute gap in research volume.
Interpretation
Shannon entropy of the trial distribution was 2.
Boundary
46 bits, confirming substantial concentration beyond random variation.
Extra
These results indicate that methodological capacity gaps limit the quality and impact of African clinical research output.
Extra
Interpretation is limited by reliance on ClinicalTrials.
Extra
gov alone, which may undercount locally registered African studies.